Apollo Hospitals Enterprise Limited Business Intelligence Report
Apollo Hospitals Enterprise Limited Business Intelligence Report
Executive Cockpit
Latest Quarterly Earnings Summary
Loading latest quarter…
You're viewing a short preview. The full Business Intelligence Report covers 20+ in-depth sections.
AI Summary
Apollo Hospitals (AHEL) is Asia's foremost integrated healthcare provider, operating a robust 10,200-bed network across 73 hospitals. The firm has successfully transitioned from a pure-play hospital chain to an omnichannel health powerhouse through Apollo 24/7 and its massive pharmacy network. Over the last decade, sales have grown at a 15% CAGR, transitioning from capital-intensive hospital builds to high-utilization and digital-led growth. While the stock trades at a premium P/E of 62.8, it reflects the company's dominance in the Indian private healthcare ecosystem and its successful…
Key Changes in FY2026
Apollo has evolved from a single hospital in 1983 to a massive integrated healthcare provider spanning 73 hospitals and over 5,000 pharmacy stores. The last decade has seen a critical shift from a purely brick-and-mortar hospital chain to an omni-channel healthcare ecosystem including diagnostics, primary care, and the 'Apollo 24/7' digital platform. Strategic moves like the hive-off of the pharmacy business and the focus on high-ARPOB (Average Revenue Per Occupied Bed) centers demonstrate a transition up the value chain. Specialized investments in Proton Therapy and Robotic Surgery have solidified its position as a tertiary care leader. The expansion into retail healthcare has diversified the revenue stream away from purely inpatient services. This evolution has allowed the company to…
Management Commentary
Led by the vision of Dr. Prathap C. Reddy, management has demonstrated high transparency and strategic clarity over four decades. The transition to the next generation of leadership among the four daughters has been seamless and well-received by the market. Concall transcripts show a deep focus on operational metrics like ARPOB, ALOS (Average Length of Stay), and digital conversion rates. There is a clear emphasis on 'clinical excellence' paired with 'digital transformation,' suggesting management is future-proofing the business. The voluntary resignation of some senior executives like the President of Oncology is a monitorable, but institutional trust remains high.
Financial Highlights
The financial profile is characterized by steady 15% revenue growth and an impressive 78% PAT CAGR over the last 5 years, albeit from a lower base in FY18-FY21. Operating margins have stabilized in the 13-15% range as newer hospitals reach maturity and occupancy levels optimize. Profit Before Tax (PBT) reached a decade-high of ₹2,661 Cr in FY26, driven by improved ARPOB (Average Revenue Per Occupied Bed) and better case mixes. Return on Equity has seen a significant journey, climbing from 13% (10y average) to a current healthy 22.1%. Management has shown efficiency in controlling raw material costs in the pharmacy segment while scaling healthcare services.
Impact Balance
Balanced PictureTop 5 Positives
Strong 5-year Profit CAGR of 78%
High · 75 · GrowthMarket leader in Indian private healthcare with 10k+ beds
High · 66 · Market PositionDiversified revenue across hospitals, pharmacy, and digital
Moderate · 64 · GrowthHighly professional management with long-term vision
Moderate · 50 · ManagementConsistent improvement in OPM from 10% to 15%
Moderate · 49 · General
Top 5 Negatives
Significant increase in debt in FY25-FY26
High · 79 · SolvencyHigh capital intensity requiring constant debt/equity updates
High · 78 · SolvencyDeclining promoter holding over the last 10 years
Moderate · 56 · ManagementExtremely high valuation (Price-to-Book ~13x)
Moderate · 54 · ValuationRegulatory risks regarding medical pricing and compliance
Moderate · 52 · Regulatory/Macro
Inside the Full Intelligence Dossier · 20+ Sections
A preview of what the complete report analyses for this company.
About Apollo Hospitals Enterprise Limited's Annual Report & Financial Performance
The latest Apollo Hospitals Enterprise Limited annual report (FY2026) is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis, audited financial statements, the director's report, the corporate governance and auditor's reports, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This Business Intelligence Hub consolidates the official filings with AI-generated financial analysis so investors can see how revenue, operating margin, cash flow quality, capex, dividends, net debt and management outlook have changed — without reading the entire filing.
What this Apollo Hospitals Enterprise Limited research covers
- Fundamental & business analysis
- Financial statements & performance
- Management commentary & discussion
- Corporate governance & auditor report
- Cash flow analysis & capital allocation
- Valuation analysis & business quality
- Growth analysis & competitive position
- Risk, SWOT & moat analysis
- Quarterly earnings & conference-call summary
- Sector, industry & peer comparison
- Latest official company filings
- Business outlook & long-term growth
Apollo Hospitals Enterprise Limited — Frequently Asked Questions
Explore more Apollo Hospitals Enterprise Limited research
AI Top Insights — Premium
Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.